Concepedia

Mario Acunzo

MA

Statistics

Publications

37

Citations

2.9K

H-Index

27

Active since

2003

Affiliations

The Ohio State University(Current)

Virginia Commonwealth University

Sapienza University of Rome

Institute for Experimental Endocrinology and Oncology

Icahn School of Medicine at Mount Sinai

Mario Acunzo is an author at The Ohio State University specializing in molecular biology, life sciences, and molecular oncology.

Publications per year

2003–2024

37

Publications

37

RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

Michela Garofalo, Gianpiero Di Leva, Giulia Romano et al. · Cancer Cell · 2009 · 735 citations · Full text

Medicine, Molecular Biology, Oncology +16

miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222

Mario Acunzo, Rosa Visone, Giulia Romano et al. · Oncogene · 2011 · 194 citations

Life Sciences, Cancer Biology, Molecular Biology +14

MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation

Giulia Romano, Mario Acunzo, Michela Garofalo et al. · Proceedings of the National Academy of Sciences · 2012 · 166 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21

Tae Jin Lee, Ji Young Yoo, Dan Shu et al. · Molecular Therapy · 2017 · 146 citations · Full text

Pharmacy, Biotechnology, Oncology +17

miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia

Rosa Visone, Angelo Veronese, Laura Z. Rassenti et al. · Blood · 2011 · 123 citations · Full text

Medicine, Molecular Biology, Oncology +14

1–5 of 37